James C. Hamilton - 06 Jan 2026 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Chief Medical Officer
Signature
/s/James Hamilton
Issuer symbol
ARWR
Transactions as of
06 Jan 2026
Net transactions value
$0
Form type
4
Filing time
08 Jan 2026, 18:45:55 UTC
Previous filing
05 Jan 2026
Next filing
09 Mar 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"James C. Hamilton filed Form 4 for ARROWHEAD PHARMACEUTICALS, INC. (ARWR) on 08 Jan 2026."

Quick Takeaways

  • This page summarizes James C. Hamilton's Form 4 filing for ARROWHEAD PHARMACEUTICALS, INC. (ARWR).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 08 Jan 2026, 18:45.

What Changed

  • Previous filing in this sequence was filed on 05 Jan 2026.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hamilton James C Chief Medical Officer 177 EAST COLORADO BLVD, SUITE 700, PASADENA /s/James Hamilton 08 Jan 2026 0001830755

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Award $0 +75,000 +44% $0.000000 246,958 06 Jan 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying restricted stock units which will vest in four equal annual installments.
F2 Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.

Sponsored